New HCV Test Enables Diagnosis and Treatment in a Single Visit
XTalks
JULY 10, 2024
The US Food and Drug Administration (FDA) has granted marketing authorization to Cepheid for its groundbreaking Xpert HCV test and GeneXpert Xpress System, marking a significant advancement in the diagnosis and treatment of hepatitis C virus (HCV). Persing, Cepheid’s chief medical and scientific officer in Cepheid’s press release.
Let's personalize your content